STOCK TITAN
  1. Home
  2. RLFTD

RLFTD (RLFTD) Stock Price, News & Analysis

RLFTD
Published by Stock Titan Data refreshed

What Changed

Company Description

RLFTD (OTC: RLFTD) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $44.9M.

This page collects what Stock Titan holds for RLFTD, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
-
-
Last updated:
-
Performance 1 year
$44.9M
Market Cap
-
Shares outstanding

RLFTD Metrics & Rankings

Market Cap
$44.9M
View ranking

Latest News

View All
—

Relief Therapeutics Reports Half-Year 2023 Financial Results and Provides Corporate Update

earnings
—

Relief Therapeutics Announces New Exclusive Definitive License Agreement for OLPRUVA(TM) (ACER-001) with Acer Therapeutics

—

RELIEF THERAPEUTICS Holding SA Announces Closing of CHF 5 Million Private Placement

private placement
—

Relief Therapeutics and World Orphan Drug Alliance Announce an Exclusive, Long-Term, Distribution Agreement to Introduce PKU GOLIKE(R) in the Middle East

—

RELIEF THERAPEUTICS Holding SA Announces Results of Annual General Meeting of Shareholders

—

RELIEF THERAPEUTICS Holding SA Announces CHF 5 Million Private Placement

private placement
—

RELIEF THERAPEUTICS Holding SA Announces Notice of Annual General Meeting of Shareholders

—

Relief Therapeutics Announces Issuance of Shares from Authorized Capital

—

Relief Therapeutics Announces Executive Leadership Team Changes

management
—

Relief Therapeutics Files Amendment No. 1 to its Registration Statement on Form F-1 with the U.S. Securities and Exchange Commission

RLFTD has 10 recent news articles. Key topics include earnings, private placement, management. View all RLFTD news →

SEC Filings

View All

No SEC filings available for RLFTD.

Financial Highlights

—
Revenue (latest FY)
—
Net Income (latest FY)
—
Diluted EPS (latest FY)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

Related Stocks

VRCA Verrica Pharmaceuticals Inc.
76.6M
ENOB Enochian Biosciences, Inc.
44.6M
GRCE Grace Therapeutics, Inc.
44.4M
CALC CalciMedica, Inc.
11.0M
PSTV PLUS THERAPEUTICS, Inc.
26.6M
ANVS Annovis Bio, Inc.
55.5M
TELO Telomir Pharmaceuticals, Inc.
80.5M
RENB Lunai Bioworks Inc.
32.9M

RLFTD Company Profile & Sector Positioning

RLFTD (RLFTD) operates in the Biotechnology industry within the broader Healthcare sector.

Investors comparing RLFTD often look at related companies in the same sector, including Verrica Pharmaceuticals Inc. (VRCA), Enochian Biosciences, Inc. (ENOB), Grace Therapeutics, Inc. (GRCE), CalciMedica, Inc. (CALC), and PLUS THERAPEUTICS, Inc. (PSTV). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate RLFTD's relative position within its industry.

Frequently Asked Questions

What is the market cap of RLFTD (RLFTD)?

The market cap of RLFTD (RLFTD) is approximately $44.9M. Learn more about what market capitalization means .